Standard Biotools (LAB) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Standard Biotools (LAB) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -6.18% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 66.99% |
| 10 | Standard Biotools | 344.96 Mn | -110.22 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,520.62% |
| Sep 30, 2025 | -10,423.28% |
| Jun 30, 2025 | -7,995.50% |
| Mar 31, 2025 | -23,046.46% |
| Dec 31, 2024 | 299.21% |
| Sep 30, 2024 | -80.81% |
| Jun 30, 2024 | -128.20% |
| Mar 31, 2024 | 79.28% |
| Dec 31, 2023 | 303.45% |
| Sep 30, 2023 | 37.44% |
| Jun 30, 2023 | 57.44% |
| Mar 31, 2023 | -953.25% |
| Sep 30, 2022 | -36.58% |
| Jun 30, 2022 | -88.41% |
| Mar 31, 2022 | -22.59% |
| Sep 30, 2021 | -228.16% |
| Jun 30, 2021 | -25.95% |
| Mar 31, 2021 | -31.19% |
| Dec 31, 2020 | -33.02% |
| Sep 30, 2020 | 80.16% |